Novel lithium alendronate compounds for the manufacture of pharmaceutical compositions comprising the compounds of the present invention and their use in the medical profession.
EP1700597A1
Pharmaceutical composition containing in association ubidecarenone, dexpanthenol and chlorhexidine or a pharmaceutically acceptable salt thereof for cutaneous application
EP2166108A1
Improved process for the production of mycophenolic acid
EP1516622A1
Stable diltiazem hydrochloride pharmaceutical composition for cutaneous application and process for the preparation thereof
EP1300140A1
Long release matricial formulations of pirlindol hydrochloride
EP1018340A1
Inclusion aminoacid salts compounds of benzimidazole derivatives with cyclodextrins, their preparation and pharmaceutical formulations containing them
EP1018335A1
Process for formulating granular matrices by precipitation of polymers in an acidic medium
EP1018364A1
Apparatus for the preparation of spherical polymer particles
